Literature DB >> 13063701

Use of a new oral diuretic, diamox, in congestive heart failure.

H BELSKY.   

Abstract

Entities:  

Keywords:  CONGESTIVE HEART FAILURE/therapy; HYDRASES; SULFONAMIDES/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13063701     DOI： 10.1056/NEJM195307232490404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy.

Authors:  J B POSNER; F PLUM
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

2.  Observations on the metabolic effects of the carbonic anhydrase inhibitor diamox: mode and rate of recovery from the drug's action.

Authors:  T HANLEY; M M PLATTS
Journal:  J Clin Invest       Date:  1956-01       Impact factor: 14.808

3.  [Significance of acidosis in carbohydrase inhibitor induced diuresis].

Authors:  W HOFFMEISTER; F KRUCK
Journal:  Klin Wochenschr       Date:  1956-04-01

4.  Usefulness of acetazolamide in the management of diuretic resistance.

Authors:  Dalvir Gill; Naga Vaishnavi Gadela; Ayesha Azmeen; Abhishek Jaiswal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-16

Review 5.  Diuretic Strategies in Acute Decompensated Heart Failure.

Authors:  E Ashley Hardin; Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2017-04

6.  The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.

Authors:  James F Knudsen; Uno Carlsson; Per Hammarström; Gerald H Sokol; Louis R Cantilena
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

7.  Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone.

Authors:  M I Khan
Journal:  Can Med Assoc J       Date:  1980-11-08       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.